Diabetes, Obesity & Metabolism

SGLT2 Inhibitors and Outcomes in Elderly Patients With Chronic Kidney Disease: A Narrative Review

By Fan Zhang, Shijie Dong, Yifei Zhong, Xianwen Zhang

ReviewInterventions

The paper

Fan Zhang, Shijie Dong, Yifei Zhong, Xianwen Zhang

Longhua Hospital Shanghai University of Traditional Chinese Medicine

Diabetes, Obesity & Metabolism, 12 Aug 2026

doi.org/10.1111/dom.71174 PubMed 42587349

Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease